What You Should Know:
- CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad patient populations, announced today it closed a $14M Series B financing round.
- The Series B round was co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures with participation from McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), and HealthX Ventures.
Inequality in
Read More
CancerIQ
Adventist Health, OSF HealthCare Use CancerIQ to Prioritize Patients for Preventive Cancer Screenings
What You Should Know:
- As the nation braces for a rise in advanced stage cancer diagnoses due to the COVID-19 pandemic, two leading health systems – Adventist Health and OSF HealthCare – are using CancerIQ’s precision prevention platform and telehealth to equitably prioritize high-risk patients for screening and identify cancer in its earliest stages.
- Clinicians to present at National Consortium of Breast Center conference on
Read More
CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform
What You Should Know:
- CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer.
- CancerIQ’s technology enables hospitals to use genomics
to personalize the prevention and early detection of cancer.
- Two new hires recently joined CancerIQ’s newly formed
Integrated Products team from Epic, with the goal of advancing CancerIQ’s
integration with leading
Read More
OSF HealthCare Integrates CancerIQ with Epic EHR to Expand Genetics to Primary Care
- OSF HealthCare integrates CancerIQ’s genetic cancer risk assessment program with Epic’s EHR platform to reduce cancer disparities and deaths. - OSF has screened nearly 70k patients using CancerIQ’s platform and will be deployed to primary care practices throughout the system. OSF HealthCare, an integrated healthcare network with locations in Illinois and Michigan, has integrated CancerIQ’s genetic cancer risk assessment program with Epic’s EHR platform as part of a system-wide population
Read More
